🇺🇸
United States · US · US:54436-020_2d07eb50-d314-a6a0-e063-6394a90ac970
Otrexup
In shortageOrange BookUNIISPLATC L04AX03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAntares Pharma, Inc.
CountryUS (United States)
ATC codeL04AX03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1154436020011 SYRINGE in 1 CARTON (54436-020-01) / .4 mL in 1 SYRINGE
- ndc1154436020031 SYRINGE in 1 CARTON (54436-020-03) / .4 mL in 1 SYRINGE
- ndc1154436020044 SYRINGE in 1 CARTON (54436-020-04) / .4 mL in 1 SYRINGE (54436-020-02)
Annotations
UNII (FDA Substance ID)
YL5FZ2Y5U1
METHOTREXATE
RxCUI 6851
Orange Book
N204824
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Methotrexate Sodium Injection
Raw payload (JSON)
{
"unii": {
"unii": "YL5FZ2Y5U1",
"rxcui": "6851",
"inchikey": "FBOZXECLQNJBKD-ZDUSSCGKSA-N",
"display_name": "METHOTREXATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"9ab8ce16-f7de-41d4-a4c8-1c742621b6d5": {
"match": "brand_token",
"title": "OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.]",
"spl_version": "15",
"published_date": "2025-02-03"
}
},
"productid": "54436-020_2d07eb50-d314-a6a0-e063-6394a90ac970",
"productndc": "54436-020",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "204824",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "10MG/0.4ML (10MG/0.4ML)",
"product_no": "001",
"approval_date": "Oct 11, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "15MG/0.4ML (15MG/0.4ML)",
"product_no": "002",
"approval_date": "Oct 11, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "20MG/0.4ML (20MG/0.4ML)",
"product_no": "003",
"approval_date": "Oct 11, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "25MG/0.4ML (25MG/0.4ML)",
"product_no": "004",
"approval_date": "Oct 11, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "7.5MG/0.4ML (7.5MG/0.4ML)",
"product_no": "005",
"approval_date": "Nov 7, 2014"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "12.5MG/0.4ML (12.5MG/0.4ML)",
"product_no": "006",
"approval_date": "Mar 24, 2016"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "17.5MG/0.4ML (17.5MG/0.4ML)",
"product_no": "007",
"approval_date": "Mar 24, 2016"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "22.5MG/0.4ML (22.5MG/0.4ML)",
"product_no": "008",
"approval_date": "Mar 24, 2016"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "10MG/0.4ML (10MG/0.4ML)",
"product_no": "009",
"approval_date": "May 31, 2017"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "15MG/0.6ML (15MG/0.6ML)",
"product_no": "010",
"approval_date": "May 31, 2017"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "17.5MG/0.7ML (17.5MG/0.7ML)",
"product_no": "011",
"approval_date": "May 31, 2017"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "20MG/0.8ML (20MG/0.8ML)",
"product_no": "012",
"approval_date": "May 31, 2017"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "22.5MG/0.9ML (22.5MG/0.9ML)",
"product_no": "013",
"approval_date": "May 31, 2017"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "25MG/ML (25MG/ML)",
"product_no": "014",
"approval_date": "May 31, 2017"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "METHOTREXATE",
"shortage_reason": "Methotrexate Sodium Injection",
"shortage_status": "current",
"proprietary_name": "Otrexup",
"active_ingred_unit": "mg/.4mL",
"application_number": "NDA204824",
"marketing_category": "NDA",
"nonproprietary_name": "methotrexate",
"start_marketing_date": "20131011",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code L04AX03.
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 10 mg 0,40 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 12,5 mg 0,31 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 15 mg 0,38 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 17,5 mg 0,44 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 20 mg 0,50 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 25 mg 0,63 mlS.F. GROUP Srl
- 🇮🇹AFSLAMET*4 siringhe preriempite SC 7,5 mg 0,30 mlS.F. GROUP Srl
- CAAURO-METHOTREXATEAURO PHARMA INC
Access this data programmatically
Query Otrexup and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.